AmplifyBio, Xcellbio to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
Xcell Biosciences Inc. (Xcellbio) has collaborated with AmplifyBio to streamline and improve the manufacturing process for engineered T-cell receptor (TCR) therapies targeting solid tumors.
T-cell Receptor | 21/05/2024 | By Aishwarya | 221
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy